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ABSTRACT 
Objective: To develop an accurate, precise and linear UV spectrophotometry method for simultaneous determination of Carvedilol and 
Hydrochlorothiazide in Co-Dilatrol® tablet and validate as per ICH guidelines. 
Methods: Derivative spectrophotometric methods: The amplitudes in simultaneous determination of the first order derivative of the resultant spectra at 301 
nm and at 278 nm were selected to find out Carvedilol and Hydrochlorothiazide respectively in its tablet dosage form by using methanol as a solvent. 
Results: The linearity was found to be 5-25 μg/ml for Carvedilol and Hydrochlorothiazide. The mean % recoveries were found to be 101.13% and 
99.02% for simultaneous determination of first order derivatives method of Carvedilol and Hydrochlorothiazide. For Intraday precision, Inter day 
precision % RSD was found to be 0.0082, 0.6304 and 0.0096, 0.6354 for Carvedilol and 0.0085, 0.6257 and 0.0083, 0.6398 for Hydrochlorothiazide 
respectively. Limit of Detection and Quantitation was found to be 0.7852μg/ml and 2.2539μg/ml for Carvedilol and 0.7859μg/ml and 2.3571μg/ml 
for Hydrochlorothiazide. Assay results of market formulation were found to be 100.89% for simultaneous determination of the first order 
derivatives method of Carvedilol and Hydrochlorothiazide. The proposed method has been validated as per ICH guidelines and successfully applied 
to the simultaneous determination of the first order derivatives method of Carvedilol and Hydrochlorothiazide in its tablet dosage form. 
Conclusion: A simple, accurate, precise, linear and rapid UV spectrophotometry method was developed for simultaneous determination of 
Carvedilol and Hydrochlorothiazide in Co-Dilatrol® tablet and validated as per ICH guidelines. Hence it can be used for the routine analysis of 
Carvedilol and Hydrochlorothiazide in tablets in various pharmaceutical industries. 
Keywords: Carvedilol, Hydrochlorothiazide, UV visible spectrophotometry, Method Validation, First order derivative method. 
 
INTRODUCTION 
Carvedilol is a combined alpha-and nonselective betablocker. 
Carvedilol chemically, 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-
methoxy phenoxy) ethyl amino]-, (±)-; (±)-1-(Carbazol-4-yloxy)-3-
[[2-(o-methoxy phenoxy) ethyl] amino]-2-propanol. It is a non-
selective beta blocker indicated in the treatment of mild to moderate 
congestive heart failure (CHF). [1, 2] It blocks beta-1 and beta-2 
adrenergic receptors as well as the alpha-1 adrenergic receptors. 
Carvedilol is official drug in British Pharmacopoeia. It has been 
prescribed as an antihypertensive agent and an angina agent. It is 
first beta blocker labeled in United States especially for the 
treatment of heart failure of ischemic or cardio myopathic origin 
with significant antioxidant activity.  
Relative to other beta blocker, carvedilol (CAR) has minimal inverse 
agonist indicating a reduced negative chronotropic and inotropic 
effect, which decrease its potential to worsen symptoms of heart 
failure. At high dosage, it exerts calcium channel blocking activity. 
The benefits of using CAR in patient with CHF in both single center 
and multi center trial have been reported in the literature. It 
prevents vitamin E, glutathione and SH protein depletion induced by 
oxidation stress, the main defense mechanism against tissue injury 
caused by free radical. Literature survey revealed the estimation 
methods of Carvedilol or with other drugs by UV spectrophotometry 
[3], HPLC [4, 5], calorimetric methods, flow injection analysis, and 
HPTLC. 
Hydrochlorothiazide chemically known as 6-chloro-3, 4-dihydro-2H-
1, 2, 4-benzothiadiazine-7-sulphonamide-1,1-dioxide is a 
moderately potent thiazide diuretic [9, 10]. It exerts its effect by 
reducing the reabsorption of electrolytes from the renal tubules, 
thereby increasing the excretion of sodium and chloride ions, and 
consequently of water. Hydrochlorothiazide is used in the treatment 
of hypertension either alone or with other antihypertensives [6]. 
Literature survey revealed the estimation methods of 
Hydrochlorothiazide or with other drugs by UV spectrophotometry 
[7-9] HPLC [10, 11] calorimetric method, flow injection analysis and 
HPTLC. 
Application of derivative technique of spectrophotometry offers a 
powerful tool for quantitative analysis of multi-component mixtures. 
When derivatives, the maxima and minima of the original function 
take zero values, and the inflections are converted into maxima or 
minima, respectively. The derivative curves are more structured 
than the original spectra, thus enabling very tiny differences 
between the original spectra to be identified. Derivative 
spectrophotometry provides selectivity and offers a solution in 
resolving the overlapping spectra in multi-component analysis 
without previous chemical separation.  
In the last decades, this technique has rapidly gained an application 
in the field of pharmaceutical analysis to overcome the problem of 
interference, due to substances other than analytes, commonly 
present in pharmaceutical formulations or for the combination of 
two or more drug substances.  
Lack of any published method for simultaneous spectrophotometric 
determination of Carvedilol and Hydrochlorothiazide, therefore, 
provoked us to investigate the application of derivative 
spectrophotometry for simultaneous determination of these 
compounds in pharmaceutical dosage forms using zero-crossing 
method [12, 13]. 
MATERIALS AND METHODS  
Apparatus and instrumentation 
A shimadzu 1800 UV/VIS double beam spectrophotometer with 1 cm 
matched quartz cells were used for all spectral measurements. Single 
Pan Electronic balance (CONTECH, CA 223, India) was used for 
weighing purpose. Sonication of the solutions was carried out using an 
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Ultrasonic Cleaning Bath (Spectra lab UCB 40, India). Calibrated 
volumetric glassware (Borosil®) was used for the validation study. 
Materials 
Reference standard of Carvedilol and Hydrochlorothiazide API was 
supplied as gift sample by Lupin Laboratory park Aurangabad, 
Maharashtra, India. The commercial formulation Co-Dilatrol® as 
purchased from the local market Solapur, Maharashtra, India.  
Method development 
Preparation of standard stock solution 
Stock solution was prepared by diluting 10 mg of each drug in 
sufficient quantity of methanol in separate volumetric flask and 
volume was made up to 100 ml to get the concentrations of 100 
μg/ml for each drug. Dilutions from stock solution were prepared in 
the range of 5-25 μg/ml for Carvedilol and 5-25 μg/ml for 
Hydrochlorothiazide. Methanol was used as a blank solution. 
Spectrophotometric measurements 
Zero-order spectra of standard solutions of Carvedilol (20μg/ml) 
and Hydrochlorothiazide (20 μg/ml) versus their solvent blank were 
recorded in the range of 200-400 nm (fig. 3). The first order 
derivative spectra of these solutions were obtained in the same 
range of wavelength against their blanks (fig. 4).  
The values of first order derivative amplitudes for Carvedilol in the 
presence of Hydrochlorothiazide and vice versa were measured at 
301 nm (zero-crossing of Carvedilol) and 278 nm (zero-crossing of 
Hydrochlorothiazide), respectively. The calibration curves for 
derivative spectrophotometry were constructed by plotting the drug 
concentration versus the absorbance values of the first order 
derivative spectrum, at 301 nm for Carvedilol and at 278 nm for 
Hydrochlorothiazide [14, 15]. 
 
  
Fig. 1: Chemical structure of Carvedilol Fig. 2: Chemical structure of Hydrochlorothiazide 
 
 
Fig. 3: Zero order spectra (overlain) of Carvedilol 20 μg/ml (A) 
and Hydrochlorothiazide 20 μg/ml (B) 
 
Fig. 4: First order derivative spectra (overlain) of Carvedilol 20 
μg/ml (A) and Hydrochlorothiazide 20 μg/ml (B) 
 
Analysis of commercial tablet formulation 
Contents of 20 tablets were weighed and their average weight was 
determined and powdered. Accurately weighed powder equivalent 
to fill weight of one tablet was transferred to 100 ml calibrated flask 
containing 50 ml of methanol and sonicated for 30 minutes. The 
volume was then made up to the mark with methanol. The resulting 
solution was then filtered through what mann filter paper (#41). 
From this solution, 1 ml was transferred to another 10 ml calibrated 
flask and diluted up to 10 ml which gives 200 μg/ml concentration of 
the solution. Then 1 ml of this solution was further diluted to 10 ml 
to get approximate concentration 20 μg/ml of Carvedilol and 20 
μg/ml of Hydrochlorothiazide. 
 












1 20 99.47   
2 20 102.92 100.89 0.5421 
3 20 100.28   
 Note:-*n=3, % RSD = % Relative standard deviation. 
 
RESULTS AND DISCUSSION 
The proposed simultaneous determination method provides simple, 
specific, precise, accurate and reproducible quantitative analysis for 
determination of Carvedilol and Hydrochlorothiazide in Co-Dilatrol® 
tablets. The method was validated as per ICH guidelines in terms of 
specificity, linearity, accuracy, precision, limits of detection (LOD) 
and quantification (LOQ), robustness and reproducibility. The 
proposed method can be used for routine analysis and quality 
control assay of Carvedilol and Hydrochlorothiazide in bulk and 
tablet formulations. 
Linearity and range 
Linearity 
Calibration curves were constructed using six replicates of 
Carvedilol solutions between 5-25 μg/ml in the presence of 5-25 
μg/ml of Hydrochlorothiazide. The same procedure was used for 
solutions containing Hydrochlorothiazide 5-25 μg/ml in the 
presence of 5-25 μg/ml of Carvedilol. The calibration curves were 
constructed (fig. 5 and fig. 6) and statistical analysis were 
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performed. The regression equations of calibration curves were 
y=0.017x+0.001 (r2=0.9997) at 301 nm for Carvedilol and 
y=0.016x+0.005 (r2=0.9994) at 278 nm for Hydrochlorothiazide for 
first order derivative spectrophotometry methods. The range was 
found to be 5-25 μg/ml for both drugs for second order 
spectrophotometry methods. 
 
Fig. 5: Calibration curve for carvedilol at 301 nm 
 
 
Fig. 6: Calibration curve for hydrochlorothiazide at 278 nm 
 
Table 2: Stastical data for the calibration graphs for 
determination of carvedilol and hydrochlorothiazide by 
proposed methods 
Parameters Carvedilol Hydrochlorothiazide 
Linearity range (µg/ml)* 5-25 5-25 
r2±SD* 0.9997 0.9995 
Note:-*n=3, SD.: Standard deviation 
 
Fig. 7: First order derivative overlay of carvedilol and 




For accuracy determination, the analysed samples were spiked with 
extra 80%, 100% and 120% of the standard solution of both drugs 
and the mixtures were re analysed by the proposed method. The 
experiment was conducted in triplicate. This was done to check for 
the recovery of the drug at different levels in the commercial tablet 
formulations. The mean recoveries and % RSD are illustrated in 
table 3. The data indicates that the proposed derivative 
spectrophotometric method is highly reproducible during one run 
and between different runs. 
Precision 
To determine the precision of the method, Carvedilol and 
Hydrochlorothiazide solutions at a concentration of 20μg/ml were 
analysed each three times for first order spectrophotometric 
method. Solutions for the standard curves were prepared fresh 
every day. 
 
Table 3: Results of drug content and analytical recovery of carvedilol and hydrochlorothiazide 
Parameters Carvedilol % RSD Hydrochlorothiazide % RSD 
Labelled claim  25 mg - 12.5 mg - 
% Drug content±SD 101.13±0.1302 0.36 99.02±0.1982 0.39 
Analytical recovery at 80 %±SD 99.58±0.2854 0.14 100.14±0.4596 0.17 
Analytical recovery at 100 %±SD 100.02±0.1335 0.24 100.01±0.4258 0.29 
Analytical recovery at 120%±SD  101.11±0.5279 0.19 99.07±0.5811 0.16 
 
Table 4: Results of intra and inter day precision 
Parameters Intraday precision Inter day precision 
SD* % RSD* S. D* % RSD* 
Carvedilol 0.0082 0.6304 0.0096 0.6354 
Hydrochlorothiazide 0.0085 0.6257 0.0083 0.6398 
Note:-*n=3, SD: standard deviation 
 
Sensitivity 
The limit of detection (LOD) and limit of quantification (LOQ) were 
calculated by using the equations LOD = 3xσ/S and LOQ = 10xσ/S, 
where σ is the standard deviation of intercept, S is the slope.  
The LOD and LOQ were found to be 0.7852μg/ml and 2.3539μg/ml 
respectively of Carvedilol for first order derivative and 0.7859μg/ml 
and 2.3571μg/ml respectively of Hydrochlorothiazide for the first 
order derivative. 
Analysis of the marketed formulation 
There was no interference from the excipients commonly present in 
the tablets. The drug content was found to be 100.89% first order 
spectrophotometric methods. It may therefore be inferred that 
degradation of Carvedilol and Hydrochlorothiazide had not occurred 
in the marketed formulations that were analysed by this method. 
The low % RSD value indicated the suitability of this method for 
routine analysis of Carvedilol and Hydrochlorothiazide in 
pharmaceutical dosage form. 
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Table 5: Summary of validation parameters 
Parameter Carvedilol Hydrochlorothiazide 
λ range 200-400 nm 200-400 nm 
Regression Equation (y=mx+c) Y=0.017x+0.001 Y=0.016x+0.005 
Measured wavelength 301 nm 278 nm 
Linearity range 5-25µg/ml 5-25µg/ml 
Slope 0.017 0.016 
Intercept 0.001 0.005 
Correlation coefficient (R2) 0.9997 0.9994 
Limit of Detection (LOD) µg/ml 0.7852 0.7859 
Limit of Quantitation (LOQ) µg/ml 2.2539 2.3571 
Accuracy (Mean % Recovery) 101.13 99.02 
Precission (%RSD) 0.36 0.39 
 
CONCLUSION 
From the results of this study it can be concluded that the proposed 
first order derivative spectrophotometric method can be used for 
simultaneous determination of Carvedilol and Hydrochlorothiazide. 
This method is simple, rapid, practical, reliable and inexpensive and 
can be used for routine analysis of simultaneous determination of 
these compounds without any prior separation in quality control 
laboratories. 
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